This page has moved to here!
This project was planned by Medical Communications as a visual way to recognize the unique talents and contributions of our faculty to education, research, clinical care and community service. The pilot campaign included six faculty from the Department of Medicine, and was awarded a Bronze Medal in the 2012 CASE Communications Awards competition sponsored by the Council for the Advancement and Support of Education District I division.
The project will be expanded in the months ahead to celebrate the achievements of UVM faculty, staff, students and alumni. Read more about the campaign's CASE award. Click on each image below for the PDF version.
Guided by his keen knowledge of blood chemistry and more than two decades of experience fighting heart disease and its related ailments, cardiologist and Professor of Medicine David Schneider, M.D., has been granted several U.S. patents for methods that deal with platelets, the microscopic particles involved in clotting and other vital processes within the bloodstream. His innovative discoveries help him and physicians around the world to better determine bleeding risks after invasive procedures and help reduce the incidence of dangerous clotting. He brings that leading-edge, inventive approach every day to the laboratory and to the clinic to help his patients, guide his students and inspire his colleagues.
An insatiable curiosity, combined with meticulous attention to detail and infinite patience, is what makes immunobiology expert and Professor of Medicine Mercedes Rincon, Ph.D., so good at what she does. Her laboratory investigations pinpoint the cellular activity that plays a role in immune system response, and have led to the identification of potential therapy targets for such diseases as flu infection, asthma, rheumatoid arthritis and breast cancer. She is also internationally known for her work with transgenic mice, uncovering how certain proteins can affect drug resistance, alter the direction of an immune response, or impact the progression of diseases. At the University of Vermont College of Medicine, she brings this passion for discovery to her work every day.
The highly-developed skills and laser-sharp precision of dermatologist and Professor of Medicine Glenn Goldman, M.D., make him a true craftsman in his field. Specially trained in Mohs surgery, a microscopic surgical treatment procedure for skin cancer, he combines a keenly focused accuracy with the detective skills of a pathologist and the restorative eye of a reconstructive surgeon to deliver successful results for his patients. His dedication to excellence fuels his leadership roles both nationally, on the American College of Mohs Surgery Board of Directors, and on campus as director of the Division of Dermatology at the University of Vermont College of Medicine.
Professor of Medicine Mary Cushman, M.D., M.Sc., has for over 15 years worked with teams of physicians and scientists examining cardiovascular risk factors in broad populations, helping to uncover causes of vascular diseases and inform treatment guidelines. Nationally, she is a leader for the American Heart Association and a champion of their campaign to improve cardiovascular health and reduce deaths by 20 percent by 2020. And as director of the Thrombosis and Hemostasis Program, she cares for patients with blood-clotting disorders and leads multidisciplinary groups focused on improving quality of care. She is a valued mentor in the laboratory and in the clinic, demonstrating her commitment every day at the UVM College of Medicine.
As a member of a prestigious FDA Advisory Committee, Associate Professor of Medicine Doris Strader, M.D., is writing the long-awaited update on groundbreaking research in protease inhibitor treatment for hepatitis C. After many years of research into the causes of and treatments for liver diseases, she was selected to coauthor the Guidelines for the Diagnosis and Management of Hepatitis C for the American Association of the Study of Liver Disease, and also co-authored the National Institutes of Health Consensus Statement on the Management of Hepatitis B. She is one of the foremost experts in the world in this area, and every day she brings this expertise to her patients, students and colleagues at the University of Vermont College of Medicine.
Actively engaged in the war on cancer, Associate Professor of Medicine Chris Holmes, M.D., Ph.D., is investigating how the three trillion platelets in our blood, which aid with clotting, can be coaxed to act as anti-cancer agents. She and her team of researchers have published an encouraging study showing that preventing platelets from releasing proteins may inhibit cancer cells from spreading, and are now looking at anti-platelet and aspirin therapy as weapons to help in this important fight. She brings that determination and unwavering commitment to her patients every day, and is an inspiration to her students and faculty colleagues at the University of Vermont College of Medicine.
Last modified February 27 2017 10:06 AM